Home > Cashflow Statement > GENPHARMASEC

GENPHARMASEC
Cashflow Statement

GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Cashflow Statement History

[Consolidated]

Mar2024Mar2023
Profit Before Tax₹0.25 Cr₹0.28 Cr
Adjustment ₹0.39 Cr₹0.16 Cr
Changes In working Capital ₹-3.54 Cr₹-3.77 Cr
Cash Flow after changes in Working Capital ₹-2.91 Cr₹-3.32 Cr
Cash Flow from Operating Activities ₹-2.95 Cr₹-3.06 Cr
Cash Flow from Investing Activities ₹-28 Cr₹0.36 Cr
Cash Flow from Financing Activities ₹48 Cr₹3.08 Cr
Net Cash Inflow / Outflow ₹17 Cr₹0.39 Cr
Opening Cash & Cash Equivalents ₹1.99 Cr₹1.61 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger --
Cash & Cash Equivalent of Subsidiaries under liquidations --
Translation adjustment on reserves / op cash balalces frgn subsidiaries --
Effect of Foreign Exchange Fluctuations --
Closing Cash & Cash Equivalent ₹19 Cr₹1.99 Cr

Compare Cashflow Statement of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹111.8 Cr NA -8.2% -14.1% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹9,585.1 Cr -1% -2.5% 36.5% Stock Analytics
KIRI INDUSTRIES ₹3,067.4 Cr -0.6% -6.5% 55.3% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹2,047.0 Cr -1.3% -3% -2.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,135.4 Cr 5.6% 9.6% 44.2% Stock Analytics
BODAL CHEMICALS ₹949.4 Cr -2% 1% -5.4% Stock Analytics


GENPHARMASEC Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC NA

-8.2%

-14.1%

SENSEX

-1.1%

-0%

3.2%


You may also like the below Video Courses